ArticleJournal of clinical medicine2022

Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed

Sang-Gon Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.